COVID-19-Induced Narcolepsy Type I With Cataplexy: A Short Report.

J Sleep ResMay 29, 2026 (epub)
Case ReportNeurology

Torsten Vinding Merinder, Martin Langeskov-Christensen, Filip Kirov

✦ AI-curated · Sources linked

Case in brief

A 42-year-old healthy female developed excessive daytime sleepiness, cataplexy, and hallucinations three months post-SARS-CoV-2 infection. Polysomnography revealed disturbed sleep patterns, while the multiple sleep latency test indicated a mean latency of 1 minute with REM sleep onset. Low cerebrospinal fluid hypocretin levels confirmed narcolepsy type I. Treatment with methylphenidate and venlafaxine significantly improved her symptoms and daily functioning.

What made this case unusual

This case highlights the onset of narcolepsy type I with cataplexy following COVID-19, contributing to the limited literature on this association.

Diagnostic / clinical pearl

Clinicians should consider narcolepsy type I in patients experiencing persistent fatigue and hypersomnolence after COVID-19, as early diagnosis can lead to effective management.

Why it matters

Understanding the potential neurological sequelae of COVID-19, including narcolepsy, is crucial for timely intervention and improved patient outcomes.

Source

Published in J Sleep Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.